EC Number   |
Application |
Reference |
|---|
   2.7.4.22 | drug development |
as bacterial UMP kinases have no counterpart in eukaryotes, the information provided here can help the design of new antibiotics |
665637 |
| 2.7.4.22 | drug development |
potential drug target for development of antimicrobial agents, diseases such as urethritis and prostatitis |
692284 |
| 2.7.4.22 | drug development |
potential target for antibacterial drugs |
665362 |
| 2.7.4.22 | drug development |
since bacterial UMPKs are specific for the phosphorylation of UMP only and differ from eukaryotic dual-specificity UMP/CMP kinases |
-, 690286 |
| 2.7.4.22 | drug development |
the enzyme is a potential antibacterial drug target |
692284 |
| 2.7.4.22 | drug development |
the enzyme is a potential drug target for developing novel anti-tuberculosis drugs |
-, 738429 |
| 2.7.4.22 | drug development |
the enzyme is a target for antimicrobial drug development |
671130 |
| 2.7.4.22 | drug development |
the enzyme is found only in bacteria and is a target for the discovery of antibacterials |
-, 737591 |
| 2.7.4.22 | drug development |
UMP kinase may be a potential antimicrobial target |
666054 |
| 2.7.4.22 | medicine |
interest in new therapies against anthrax has arisen from its potential for bioterrorism. The allosteric pocket of the enzyme, with its atypical configuration of side chains, may provide a particularly suitable site for pharmacological intervention |
-, 693652 |
